Cold And Flu Drugs Global Market Report 2025

Description

Cold and flu drugs are pharmaceutical medications designed to alleviate symptoms associated with the common cold and influenza (flu). These medications help relieve symptoms such as fever, cough, congestion, sore throat, body aches, and others, improving comfort and supporting recovery.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of cold and flu drugs include antihistamines, expectorants, bronchodilators, decongestants, and other variants. Antihistamines are drugs that block histamine receptors to relieve allergy and cold symptoms such as sneezing, itching, and nasal congestion. These drugs come in various dosage forms, including tablets, capsules, syrups, lozenges, and others. They are used for a range of conditions, including congenital pituitary dwarfism, acquired pituitary dwarfism, genetic syndromes, and other hormonal disorders. These medications are administered to patients across various age groups, including pediatric, adolescent, adult, and geriatric populations. They are used by several end-users, such as hospitals, specialized clinics, homecare settings, pharmaceutical companies, and research institutions.

The cold and flu drugs market research report is one of a series of new reports from The Business Research Company that provides cold and flu drugs market statistics, including the cold and flu drugs global market size, regional shares, competitors with the cold and flu drugs market share, detailed cold and flu drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the cold and flu drugs. This cold and flu drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cold and flu drugs market size has grown rapidly in recent years. It will grow from $17.35 billion in 2024 to $19.19 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth observed during the historic period can be attributed to the increasing aging population, the growing popularity of over-the-counter (OTC) medications, expanding urbanization, rising demand for herbal and natural remedies, and higher healthcare expenditure.

The cold and flu drugs market size is expected to see rapid growth in the next few years. It will grow to $28.54 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth projected during the forecast period can be attributed to the increasing prevalence of seasonal influenza, the rise in air pollution contributing to respiratory infections, the growing cases of antibiotic resistance, the rising popularity of immunity-boosting supplements, and heightened awareness about self-medication. Key trends during this period include personalized medicine, the development of combination products and natural remedies, advancements in nasal sprays and inhalers, strategic collaborations, and the creation of fast-acting formulations.

The growing frequency of viral infections is expected to drive the expansion of the cold and flu drugs market in the future. A viral infection is caused when viruses invade and multiply within host cells, leading to a variety of symptoms. The rise in viral infections is primarily due to increased travel, which facilitates the spread of viruses across regions and countries, enabling them to reach new populations and cause outbreaks. Cold and flu drugs help manage viral infections by alleviating symptoms such as fever, congestion, and pain, offering relief while the immune system works to fight the virus. For example, in January 2025, the Pan American Health Organization, a U.S.-based agency focused on international health cooperation in the Americas, reported a 22.05% influenza positivity rate globally in early January 2025, marking a 20% seasonal increase. Thus, the rising incidence of viral infections is contributing to the growth of the cold and flu drugs market.

Leading companies in the cold and flu drugs market are focusing on developing innovative products, such as clean over-the-counter (OTC) medicines, to provide safer, natural alternatives for children, free from artificial additives. Over-the-counter (OTC) medicines are drugs that can be purchased without a prescription, commonly used for treating everyday conditions such as headaches, colds, and minor pain. For instance, in September 2023, Genexa Inc., a U.S.-based clean medicine company, launched clean OTC children's medicines, including the Kids' Multi-Symptom Cold & Flu and Kids' Daytime + Nighttime Cough Relief Value Pack. These products feature effective active ingredients without artificial dyes, sweeteners, or preservatives, providing a safer and more natural alternative for treating children's cold and flu symptoms, while offering relief for issues such as fever, sore throat, and congestion.

In February 2023, Vir Biotechnology Inc., a U.S.-based biotechnology firm, formed a partnership with GlaxoSmithKline to develop new therapies for influenza. This collaboration aims to ensure continued access to sotrovimab for authorized patients, while also jointly advancing the development of new treatments for influenza and other respiratory illnesses. Additionally, Vir Biotechnology is pursuing next-generation solutions for COVID-19 and potential future coronavirus outbreaks. GlaxoSmithKline is a U.K.-based biopharma company specializing in over-the-counter (OTC) medications for cold and flu symptoms.

Major players in the cold and flu drugs market are Johnson & Johnson, Roche Holding AG, Bayer AG, Sanofi S.A., Viatris Inc., Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Pyxus International Inc., Glenmark Pharmaceuticals Ltd., The Kroger Co., Saphnix Life Sciences, Arlak Biotech Pvt Ltd, AdvaCare Pharma, Sterling Pharmaceuticals, Biophar Lifesciences Pvt Ltd, Nutra Respiro.

North America was the largest region in the cold and flu drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cold and flu drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cold and flu drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold and flu drugs market consist of sales of cough suppressants, nasal sprays, antiviral medications, sore throat sprays, and fever reducers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cold And Flu Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cold and flu drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cold and flu drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold and flu drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Antihistamines; Expectorants; Bronchodilators; Decongestants; Other Types
2) By Dosage Form: Tablets; Capsules; Syrups; Lozenges; Other Dosage Forms
3) By Indication: Congenital Pituitary Dwarfism; Acquired Pituitary Dwarfism; Genetic Syndromes; Other Hormonal Disorders
4) By Age Group: Pediatric Patients; Adolescent Patients; Adult Patients; Geriatric Patients
5) By End-User: Hospitals; Specialized Clinics; Homecare Settings; Pharmaceuticals And Research Institutions
Subsegments:
1) By Type: First-Generation Antihistamines; Second-Generation Antihistamines; Combination Antihistamines
2) By Type: Guaifenesin-Based Expectorants; Herbal Expectorants; Combination Expectorants
3) By Type: Beta-Agonists; Anticholinergics; Combination Bronchodilators
4) By Type: Oral Decongestants; Nasal Spray Decongestants; Combination Decongestants
5) By Type: Pain Relievers; Cough Suppressants; Antipyretics; Nasal Sprays; Immune Boosters
Companies Mentioned: Johnson & Johnson; Roche Holding AG; Bayer AG; Sanofi S.A.; Viatris Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r34796

1. Executive Summary

2. Cold And Flu Drugs Market Characteristics

3. Cold And Flu Drugs Market Trends And Strategies

4. Cold And Flu Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cold And Flu Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Cold And Flu Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cold And Flu Drugs Market Growth Rate Analysis
5.4. Global Cold And Flu Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cold And Flu Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cold And Flu Drugs Total Addressable Market (TAM)

6. Cold And Flu Drugs Market Segmentation

6.1. Global Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Expectorants
Bronchodilators
Decongestants
Other Types
6.2. Global Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Syrups
Lozenges
Other Dosage Forms
6.3. Global Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Congenital Pituitary Dwarfism
Acquired Pituitary Dwarfism
Genetic Syndromes
Other Hormonal Disorders
6.4. Global Cold And Flu Drugs Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric Patients
Adolescent Patients
Adult Patients
Geriatric Patients
6.5. Global Cold And Flu Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialized Clinics
Homecare Settings
Pharmaceuticals And Research Institutions
6.6. Global Cold And Flu Drugs Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-Generation Antihistamines
Second-Generation Antihistamines
Combination Antihistamines
6.7. Global Cold And Flu Drugs Market, Sub-Segmentation Of Expectorants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Guaifenesin-Based Expectorants
Herbal Expectorants
Combination Expectorants
6.8. Global Cold And Flu Drugs Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Beta-Agonists
Anticholinergics
Combination Bronchodilators
6.9. Global Cold And Flu Drugs Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Decongestants
Nasal Spray Decongestants
Combination Decongestants
6.10. Global Cold And Flu Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Relievers
Cough Suppressants
Antipyretics
Nasal Sprays
Immune Bosters

7. Cold And Flu Drugs Market Regional And Country Analysis

7.1. Global Cold And Flu Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cold And Flu Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cold And Flu Drugs Market

8.1. Asia-Pacific Cold And Flu Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cold And Flu Drugs Market

9.1. China Cold And Flu Drugs Market Overview
9.2. China Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cold And Flu Drugs Market

10.1. India Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cold And Flu Drugs Market

11.1. Japan Cold And Flu Drugs Market Overview
11.2. Japan Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cold And Flu Drugs Market

12.1. Australia Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cold And Flu Drugs Market

13.1. Indonesia Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cold And Flu Drugs Market

14.1. South Korea Cold And Flu Drugs Market Overview
14.2. South Korea Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cold And Flu Drugs Market

15.1. Western Europe Cold And Flu Drugs Market Overview
15.2. Western Europe Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cold And Flu Drugs Market

16.1. UK Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cold And Flu Drugs Market

17.1. Germany Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cold And Flu Drugs Market

18.1. France Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cold And Flu Drugs Market

19.1. Italy Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cold And Flu Drugs Market

20.1. Spain Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cold And Flu Drugs Market

21.1. Eastern Europe Cold And Flu Drugs Market Overview
21.2. Eastern Europe Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cold And Flu Drugs Market

22.1. Russia Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cold And Flu Drugs Market

23.1. North America Cold And Flu Drugs Market Overview
23.2. North America Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cold And Flu Drugs Market

24.1. USA Cold And Flu Drugs Market Overview
24.2. USA Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cold And Flu Drugs Market

25.1. Canada Cold And Flu Drugs Market Overview
25.2. Canada Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cold And Flu Drugs Market

26.1. South America Cold And Flu Drugs Market Overview
26.2. South America Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cold And Flu Drugs Market

27.1. Brazil Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cold And Flu Drugs Market

28.1. Middle East Cold And Flu Drugs Market Overview
28.2. Middle East Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cold And Flu Drugs Market

29.1. Africa Cold And Flu Drugs Market Overview
29.2. Africa Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cold And Flu Drugs Market Competitive Landscape And Company Profiles

30.1. Cold And Flu Drugs Market Competitive Landscape
30.2. Cold And Flu Drugs Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cold And Flu Drugs Market Other Major And Innovative Companies

31.1. Reckitt Benckiser Group plc
31.2. Sun Pharmaceutical Industries Ltd.
31.3. Perrigo Company plc
31.4. Dr. Reddy's Laboratories Ltd.
31.5. Hikma Pharmaceuticals plc
31.6. Lupin Limited
31.7. Pyxus International Inc.
31.8. Glenmark Pharmaceuticals Ltd.
31.9. The Kroger Co.
31.10. Saphnix Life Sciences
31.11. Arlak Biotech Pvt Ltd
31.12. AdvaCare Pharma
31.13. Sterling Pharmaceuticals
31.14. Biophar Lifesciences Pvt Ltd
31.15. Nutra Respiro

32. Global Cold And Flu Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cold And Flu Drugs Market

34. Recent Developments In The Cold And Flu Drugs Market

35. Cold And Flu Drugs Market High Potential Countries, Segments and Strategies

35.1 Cold And Flu Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Cold And Flu Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Cold And Flu Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250617_r34796_Cold_And_Flu_Drugs_GMR_2025